Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) - Total Liabilities

Latest as of March 2026: CN¥3.71 Billion CNY ≈ $542.17 Million USD

Based on the latest financial reports, Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) has total liabilities worth CN¥3.71 Billion CNY (≈ $542.17 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd - Total Liabilities Trend (2013–2025)

This chart illustrates how Nanjing King-friend Biochemical Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 603707 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Nanjing King-friend Biochemical Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Fibra Terrafina MX:TERRA13	Mexico	MX$19.87 Billion
WeRide Inc. American Depositary Shares NASDAQ:WRD	USA	$1.00 Billion
Shenzhen JingQuanHua Electronics Co Ltd SHE:002885	China	CN¥1.58 Billion
German American Bancorp Inc NASDAQ:GABC	USA	$7.21 Billion
Saurer Intelligent Technology Co Ltd Class A SHG:600545	China	CN¥5.73 Billion
TBO Tek Ltd NSE:TBOTEK	India	Rs58.86 Billion
Tien Phong Commercial Joint Stock Bank VN:TPB	Vietnam	₫459.85 Trillion
Deterra Royalties Ltd AU:DRR	Australia	AU$236.22 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Nanjing King-friend Biochemical Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Nanjing King-friend Biochemical Pharmace (603707) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.27	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.53	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.35	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Nanjing King-friend Biochemical Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Nanjing King-friend Biochemical Pharmaceutical Co Ltd (2013–2025)

The table below shows the annual total liabilities of Nanjing King-friend Biochemical Pharmaceutical Co Ltd from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥3.44 Billion ≈ $503.85 Million	+13.95%
2024-12-31	CN¥3.02 Billion ≈ $442.18 Million	-18.89%
2023-12-31	CN¥3.73 Billion ≈ $545.20 Million	-3.05%
2022-12-31	CN¥3.84 Billion ≈ $562.34 Million	+36.56%
2021-12-31	CN¥2.81 Billion ≈ $411.80 Million	-29.22%
2020-12-31	CN¥3.98 Billion ≈ $581.78 Million	+91.67%
2019-12-31	CN¥2.07 Billion ≈ $303.54 Million	+111.40%
2018-12-31	CN¥981.21 Million ≈ $143.58 Million	+52.72%
2017-12-31	CN¥642.50 Million ≈ $94.02 Million	+208.75%
2016-12-31	CN¥208.09 Million ≈ $30.45 Million	+1.65%
2015-12-31	CN¥204.72 Million ≈ $29.96 Million	-59.72%
2014-12-31	CN¥508.26 Million ≈ $74.37 Million	+265.89%
2013-12-31	CN¥138.91 Million ≈ $20.33 Million	--

About Nanjing King-friend Biochemical Pharmaceutical Co Ltd

SHG:603707 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.69 Billion

CN¥11.54 Billion CNY

Market Cap Rank

#6864 Global

#1531 in China

Share Price

CN¥7.14

Change (1 day)

+0.28%

52-Week Range

CN¥7.08 - CN¥11.94

All Time High

CN¥33.62